Literature DB >> 11994408

Pdx1 restores beta cell function in Irs2 knockout mice.

Jake A Kushner1, Jing Ye, Markus Schubert, Deborah J Burks, Matthew A Dow, Carrie L Flint, Sanjoy Dutta, Christopher V E Wright, Marc R Montminy, Morris F White.   

Abstract

The homeodomain transcription factor Pdx1 is required for pancreas development, including the differentiation and function of beta cells. Mutations in Pdx1 or upstream hepatocyte nuclear factors cause autosomal forms of early-onset diabetes (maturity-onset diabetes of the young [MODY]). In mice, the Irs2 branch of the insulin/Igf signaling system mediates peripheral insulin action and pancreatic beta cell growth and function. To investigate whether beta cell failure in Irs2(-/-) mice might be related to dysfunction of MODY-related transcription factors, we measured the expression of Pdx1 in islets from young Irs2(-/-) mice. Before the onset of diabetes, Pdx1 was reduced in islets from Irs2(-/-) mice, whereas it was expressed normally in islets from wild-type or Irs1(-/-) mice, which do not develop diabetes. Whereas male Irs2(-/-)Pdx1(+/+) mice developed diabetes between 8 and 10 weeks of age, haploinsufficiency for Pdx1 caused diabetes in newborn Irs2(-/-) mice. By contrast, transgenic expression of Pdx1 restored beta cell mass and function in Irs2(-/-) mice and promoted glucose tolerance throughout life, as these mice survived for at least 20 months without diabetes. Our results suggest that dysregulation of Pdx1 might represent a common link between ordinary type 2 diabetes and MODY.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994408      PMCID: PMC150960          DOI: 10.1172/JCI14439

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

Authors:  S S Fajans; G I Bell; K S Polonsky
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

Review 2.  IRS proteins and beta-cell function.

Authors:  D J Burks; M F White
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

3.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.

Authors:  L Rui; V Aguirre; J K Kim; G I Shulman; A Lee; A Corbould; A Dunaif; M F White
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

4.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  Attenuation of FGF signalling in mouse beta-cells leads to diabetes.

Authors:  A W Hart; N Baeza; A Apelqvist; H Edlund
Journal:  Nature       Date:  2000-12-14       Impact factor: 49.962

6.  Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1.

Authors:  M K Thomas; O N Devon; J H Lee; A Peter; D A Schlosser; M S Tenser; J F Habener
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

7.  Cloning and characterization of PHIP, a novel insulin receptor substrate-1 pleckstrin homology domain interacting protein.

Authors:  J Farhang-Fallah; X Yin; G Trentin; A M Cheng; M Rozakis-Adcock
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 8.  Ten years of protein kinase B signalling: a hard Akt to follow.

Authors:  D P Brazil; B A Hemmings
Journal:  Trends Biochem Sci       Date:  2001-11       Impact factor: 13.807

9.  PDX:PBX complexes are required for normal proliferation of pancreatic cells during development.

Authors:  S Dutta; M Gannon; B Peers; C Wright; S Bonner-Weir; M Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

10.  Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.

Authors:  N J Sund; M Z Vatamaniuk; M Casey; S L Ang; M A Magnuson; D A Stoffers; F M Matschinsky; K H Kaestner
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

View more
  75 in total

1.  Hepatocyte growth factor ameliorates hyperglycemia and corrects β-cell mass in IRS2-deficient mice.

Authors:  Juan C Alvarez-Perez; Taylor C Rosa; Gabriella P Casinelli; Shelley R Valle; Jayalakshmi Lakshmipathi; Carolina Rosselot; Francisco Rausell-Palamos; Rupangi C Vasavada; Adolfo García-Ocaña
Journal:  Mol Endocrinol       Date:  2014-12

Review 2.  Transcriptional networks controlling pancreatic development and beta cell function.

Authors:  J M Servitja; J Ferrer
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

3.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

Review 4.  Development of the endocrine pancreas.

Authors:  David J Hill
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

5.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Authors:  Xiaocheng Dong; Sunmin Park; Xueying Lin; Kyle Copps; Xianjin Yi; Morris F White
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

6.  In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1.

Authors:  Shruti D Dave; Aruna V Vanikar; Hargovind L Trivedi
Journal:  Cytotechnology       Date:  2013-05-09       Impact factor: 2.058

7.  Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice.

Authors:  Ming-Jia Niu; Jin-Kui Yang; Shan-Shan Lin; Xiu-Juan Ji; Li-Min Guo
Journal:  Endocrine       Date:  2008-10-28       Impact factor: 3.633

8.  Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.

Authors:  H Wang; M Iezzi; S Theander; P A Antinozzi; B R Gauthier; P A Halban; C B Wollheim
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

9.  Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and AKT kinases.

Authors:  Rohan K Humphrey; Shu-Mei Yu; Luis E Flores; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling.

Authors:  Timothy D Cummins; Michelle T Barati; Susan C Coventry; Sarah A Salyer; Jon B Klein; David W Powell
Journal:  Biochim Biophys Acta       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.